Article Versions Notes

Mamis E, Duchemin C, Berlin V, Bernerd C, Bovigny M, Chevallay E, Crepieux B, Gadelshin VM, Heinke R, Hernandez RM, et al. Target Development towards First Production of High-Molar- Activity ^44gSc and ⁴⁷Sc by Mass Separation at CERN-MEDICIS. Pharmaceuticals. 2024; 17(3):390. https://doi.org/10.3390/ph17030390

Mamis, Edgars, Charlotte Duchemin, Valentina Berlin, Cyril Bernerd, Mathieu Bovigny, Eric Chevallay, Bernard Crepieux, Vadim Maratovich Gadelshin, Reinhard Heinke, Ronaldo Mendez Hernandez, and et al. 2024. "Target Development towards First Production of High-Molar- Activity ^44gSc and ⁴⁷Sc by Mass Separation at CERN-MEDICIS" Pharmaceuticals 17, no. 3: 390. https://doi.org/10.3390/ph17030390

Mamis, E., Duchemin, C., Berlin, V., Bernerd, C., Bovigny, M., Chevallay, E., Crepieux, B., Gadelshin, V. M., Heinke, R., Hernandez, R. M., Johnson, J. D., Kalniņa, P., Koliatos, A., Lambert, L., Rossel, R. E., Rothe, S., Thiboud, J., Weber, F., Wendt, K., ... Stora, T. (2024). Target Development towards First Production of High-Molar- Activity ^44gSc and ⁴⁷Sc by Mass Separation at CERN-MEDICIS. Pharmaceuticals, 17(3), 390. https://doi.org/10.3390/ph17030390